Skip to Content
Morningstar

Loncar Cancer Immunotherapy ETF CNCR

Morningstar Medalist Rating
Medalist Rating as of | See Loncar Investment Hub

Morningstar’s Analysis CNCR

Will CNCR outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

  • Process Pillar

    The Process Pillar is our assessment of how sensible, clearly defined, and repeatable CNCR’s performance objective and investment process is for both security selection and portfolio construction.

  • People Pillar

    The People Pillar is our evaluation of the CNCR management team’s experience and ability. We find that high-quality management teams deliver superior performance relative to their benchmarks and/or peers.

  • Parent Pillar

    The Parent Pillar is our rating of CNCR’s parent organization’s priorities and whether they’re in line with investors’ interests.

Weakness in Loncar Cancer Immunotherapy ETF's Process and People Pillar ratings limits this strategy to a Morningstar Medalist Rating of Negative.

null Morningstar Manager Research

Morningstar Manager Research

Summary

The portfolio maintains a cost advantage over competitors, priced within the second-cheapest fee quintile among peers.

by Morningstar Manager Research
Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings CNCR

More CNCR Holdings
  • Current Portfolio Date
  • Equity Holdings —
  • Bond Holdings —
  • Other Holdings —
  • % Assets in Top 10 Holdings 19.1
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Geron Corp

3.00 526,262
Healthcare

Acrivon Therapeutics Inc

2.64 463,137
Healthcare

Enliven Therapeutics Inc

2.15 376,998
Healthcare

Janux Therapeutics Inc Ordinary Shares

1.82 319,626
Healthcare

Nuvation Bio Inc Ordinary Shares - Class A

1.72 302,157
Healthcare

2seventy bio Inc Ordinary Shares

1.65 289,941
Healthcare

Revolution Medicines Inc Ordinary Shares

1.60 281,349
Healthcare

Lyell Immunopharma Inc Ordinary Shares

1.53 269,252
Healthcare

Day One Biopharmaceuticals Inc

1.52 267,658
Healthcare

Merck & Co Inc

1.48 260,227
Healthcare